These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3720904)

  • 21. Trypanocidal activity of a 5-substituted 2-nitroimidazole compound (Ro 15-0216) in mice.
    Zweygarth E; Röttcher D
    Trop Med Parasitol; 1987 Sep; 38(3):171-4. PubMed ID: 3432951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of African trypanosomiasis.
    Williamson J
    Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
    [No Abstract]   [Full Text] [Related]  

  • 23. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

  • 25. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
    Steverding D; Rushworth SA
    Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.
    Kuepfer I; Schmid C; Allan M; Edielu A; Haary EP; Kakembo A; Kibona S; Blum J; Burri C
    PLoS Negl Trop Dis; 2012 Aug; 6(8):e1695. PubMed ID: 22970329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current therapy of trypanosomiasis].
    Doua F; Boa Yapo F
    Bull Soc Pathol Exot; 1994; 87(5):337-40. PubMed ID: 7496197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental infection of goats with Trypanosoma brucei ssp. and effects of treatment with suramin and Mel-B.
    Wellde BT; Reardon MJ; Chumo DA; Muriithi RM; Towett S; Mwangi J
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():161-9. PubMed ID: 2619390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
    Kibona SN; Matemba L; Kaboya JS; Lubega GW
    Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of calcium in trypanocidal drug action.
    Clarkson AB; Amole BO
    Science; 1982 Jun; 216(4552):1321-3. PubMed ID: 6805075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrocardiographic changes in African trypanosomiasis caused by Trypanosoma brucei rhodesiense.
    Jones IG; Lowenthal MN; Buyst H
    Trans R Soc Trop Med Hyg; 1975; 69(4):388-95. PubMed ID: 1216299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with Rhodesian trypanosomiasis.
    Harrison SM; Harris RW; Bales JD
    Am J Trop Med Hyg; 1997 Jun; 56(6):632-6. PubMed ID: 9230794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice.
    Jennings FW; Urquhart GM
    Z Parasitenkd; 1983; 69(5):577-81. PubMed ID: 6636983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis.
    Mpia B; Pépin J
    Trop Med Int Health; 2002 Sep; 7(9):775-9. PubMed ID: 12225509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New leads for trypanosomiasis chemotherapy.
    Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152
    [No Abstract]   [Full Text] [Related]  

  • 38. Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.
    Pépin J; Mpia B
    Emerg Infect Dis; 2005 Jun; 11(6):921-7. PubMed ID: 15963288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion.
    Amin DN; Masocha W; Ngan'dwe K; Rottenberg M; Kristensson K
    Acta Trop; 2008 Apr; 106(1):72-4. PubMed ID: 18329619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate catabolism.
    Clarkson AB; Brohn FH
    Science; 1976 Oct; 194(4261):204-6. PubMed ID: 986688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.